Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Investigating the Proteomic Profile of HT-29 Colon Cancer Cells After Lactobacillus kefiri SGL 13 Exposure Using the SWATH Method.

Brandi J, Di Carlo C, Manfredi M, Federici F, Bazaj A, Rizzi E, Cornaglia G, Manna L, Marengo E, Cecconi D.

J Am Soc Mass Spectrom. 2019 Sep;30(9):1690-1699. doi: 10.1007/s13361-019-02268-6. Epub 2019 Jul 15.

PMID:
31309410
2.

Did Caravaggio die of Staphylococcus aureus sepsis?

Drancourt M, Barbieri R, Cilli E, Gruppioni G, Bazaj A, Cornaglia G, Raoult D.

Lancet Infect Dis. 2018 Nov;18(11):1178. doi: 10.1016/S1473-3099(18)30571-1. Epub 2018 Sep 17. No abstract available.

PMID:
30236439
3.

Actual role of older oral antibiotics in the treatment of resistant Urinary Tract Infections (UTIs).

Concia E, Cornaglia G, Novelli A.

J Chemother. 2017 Dec;29(sup1):1. doi: 10.1080/1120009X.2017.1380394. No abstract available.

PMID:
29271737
4.

Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: a review.

Mazzariol A, Bazaj A, Cornaglia G.

J Chemother. 2017 Dec;29(sup1):2-9. doi: 10.1080/1120009X.2017.1380395. Review.

PMID:
29271736
5.

Field evaluation of two point-of-care tests for syphilis among men who have sex with men, Verona, Italy.

Zorzi A, Cordioli M, Gios L, Del Bravo P, Toskin I, Peeling RW, Blondeel K, Cornaglia G, Kiarie J, Ballard R, Mirandola M.

Sex Transm Infect. 2017 Dec;93(S4):S51-S58. doi: 10.1136/sextrans-2016-053065.

6.

Place of International Congresses in the Diffusion of Knowledge in Infectious Diseases.

Lassmann B, Cornaglia G.

Clin Infect Dis. 2017 Aug 15;65(suppl_1):S70-S73. doi: 10.1093/cid/cix348.

PMID:
28859343
7.

How is post-mortem microbiology appraised by pathologists? Results from a practice survey conducted by ESGFOR.

Saegeman V, Cohen MC, Alberola J, Ziyade N, Farina C; ESCMID Study Group for Forensic and Postmortem Microbiology, Cornaglia G, Fernández-Rodríguez A.

Eur J Clin Microbiol Infect Dis. 2017 Aug;36(8):1381-1385. doi: 10.1007/s10096-017-2943-6. Epub 2017 Feb 24.

PMID:
28236029
8.

blaNDM-1 Carriage on IncR Plasmid in Enterobacteriaceae Strains.

Kocsis E, Gužvinec M, Butić I, Krešić S, Crnek SŠ, Tambić A, Cornaglia G, Mazzariol A.

Microb Drug Resist. 2016 Mar;22(2):123-8. doi: 10.1089/mdr.2015.0083. Epub 2015 Oct 20.

PMID:
26484384
9.

Palaeomicrobiology meets forensic medicine: time as a fourth-dimension for the crime scene.

Bazaj A, Turrina S, De Leo D, Cornaglia G.

New Microbes New Infect. 2015 Jan 12;4:5-6. doi: 10.1016/j.nmni.2014.12.006. eCollection 2015 Mar.

10.

The clinical positioning of telavancin in Europe.

Masterton R, Cornaglia G, Courvalin P, Lode HM, Rello J, Torres A.

Int J Antimicrob Agents. 2015 Mar;45(3):213-20. doi: 10.1016/j.ijantimicag.2014.12.006. Epub 2014 Dec 24. Review.

PMID:
25600892
11.

Cross-reactivity of Nocardia spp. in the fungal (1-3)-β-d-glucan assay performed on cerebral spinal fluid.

Koncan R, Favuzzi V, Ligozzi M, Sorrentino A, Cornaglia G, Cascio GL.

Diagn Microbiol Infect Dis. 2015 Feb;81(2):94-5. doi: 10.1016/j.diagmicrobio.2014.11.002. Epub 2014 Nov 29.

PMID:
25497418
12.

A case of Beauveria bassiana keratitis confirmed by internal transcribed spacer and LSU rDNA D1-D2 sequencing.

Ligozzi M, Maccacaro L, Passilongo M, Pedrotti E, Marchini G, Koncan R, Cornaglia G, Centonze AR, Lo Cascio G.

New Microbes New Infect. 2014 May;2(3):84-7. doi: 10.1002/nmi2.30. Epub 2014 May 20.

13.

Interference of confounding factors on the use of (1,3)-beta-D-glucan in the diagnosis of invasive candidiasis in the intensive care unit.

Lo Cascio G, Koncan R, Stringari G, Russo A, Azzini A, Ugolini A, Ligozzi M, Polati E, Cornaglia G, Concia E, Schweiger V.

Eur J Clin Microbiol Infect Dis. 2015 Feb;34(2):357-65. doi: 10.1007/s10096-014-2239-z. Epub 2014 Sep 13.

PMID:
25217227
14.

Carbapenemases in Enterobacteriaceae: the magnitude of a worldwide concern.

Rolain JM, Cornaglia G.

Clin Microbiol Infect. 2014 Sep;20(9):819-20. doi: 10.1111/1469-0691.12737. Epub 2014 Jul 29. No abstract available.

15.

Diversity of carbapenemases in clinical isolates of Enterobacteriaceae in Croatia--the results of a multicentre study.

Zujić Atalić V, Bedenić B, Kocsis E, Mazzariol A, Sardelić S, Barišić M, Plečko V, Bošnjak Z, Mijač M, Jajić I, Vranić-Ladavac M, Cornaglia G.

Clin Microbiol Infect. 2014 Nov;20(11):O894-903. doi: 10.1111/1469-0691.12635. Epub 2014 May 15.

16.

KPC-3 carbapenemase harbored in FIIk plasmid from Klebsiella pneumoniae ST512 and Escherichia coli ST43 in the same patient.

Kocsis E, Lo Cascio G, Piccoli M, Cornaglia G, Mazzariol A.

Microb Drug Resist. 2014 Oct;20(5):377-82. doi: 10.1089/mdr.2013.0152. Epub 2014 Feb 26.

PMID:
24571419
17.

Barriers to the vaccination of children and adolescents and possible solutions.

Esposito S, Principi N, Cornaglia G; ESCMID Vaccine Study Group (EVASG).

Clin Microbiol Infect. 2014 May;20 Suppl 5:25-31. doi: 10.1111/1469-0691.12447. Epub 2014 Jan 24. Review.

18.

Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases.

Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, Cornaglia G, Garau J, Gniadkowski M, Hayden MK, Kumarasamy K, Livermore DM, Maya JJ, Nordmann P, Patel JB, Paterson DL, Pitout J, Villegas MV, Wang H, Woodford N, Quinn JP.

Lancet Infect Dis. 2013 Sep;13(9):785-96. doi: 10.1016/S1473-3099(13)70190-7. Review.

19.

Klebsiella pneumoniae harbouring OXA-48 carbapenemase in a Libyan refugee in Italy.

Kocsis E, Savio C, Piccoli M, Cornaglia G, Mazzariol A.

Clin Microbiol Infect. 2013 Sep;19(9):E409-11. doi: 10.1111/1469-0691.12232. Epub 2013 May 9.

20.

Prevalence of plasmid-mediated quinolone resistance determinants in Enterobacteriaceae strains isolated in North-East Italy.

Kocsis B, Mazzariol A, Kocsis E, Koncan R, Fontana R, Cornaglia G.

J Chemother. 2013 Feb;25(1):36-40. doi: 10.1179/1120009X12Z.00000000078.

PMID:
23433443
21.

Identification of blaLAP-₂ and qnrS1 genes in the internationally successful Klebsiella pneumoniae ST147 clone.

Kocsis B, Kocsis E, Fontana R, Cornaglia G, Mazzariol A.

J Med Microbiol. 2013 Feb;62(Pt 2):269-73. doi: 10.1099/jmm.0.050542-0. Epub 2012 Nov 1.

PMID:
23118475
22.

Welcoming countries emerging on the scene of medical sciences in Clinical Microbiology and Infection.

Raoult D, Cornaglia G, Kahlmeter G.

Clin Microbiol Infect. 2012 Nov;18(11):1055. doi: 10.1111/j.1469-0691.2012.03989.x. No abstract available.

23.

The importance of understanding the human-animal interface : from early hominins to global citizens.

Reperant LA, Cornaglia G, Osterhaus AD.

Curr Top Microbiol Immunol. 2013;365:49-81. doi: 10.1007/82_2012_269. Review.

PMID:
23042568
24.

First report of KPC-producing Klebsiella pneumoniae in Croatia.

Bedenić B, Mazzariol A, Plečko V, Bošnjak Z, Barl P, Vraneš J, Cornaglia G.

J Chemother. 2012 Aug;24(4):237-9. doi: 10.1179/1973947812Y.0000000017.

PMID:
23040691
25.

Co-infection by two linezolid-resistant coagulase-negative staphylococci with two different resistance determinants.

Mazzariol A, Kocsis E, Bragagnolo L, Pellizzer G, Rassu M, Cornaglia G.

Scand J Infect Dis. 2012 Dec;44(12):978-81. doi: 10.3109/00365548.2012.704151. Epub 2012 Jul 25.

PMID:
22830638
26.

Emergence of antibiotic resistance: need for a new paradigm.

Rolain JM, Canton R, Cornaglia G.

Clin Microbiol Infect. 2012 Jul;18(7):615-6. doi: 10.1111/j.1469-0691.2012.03902.x. No abstract available.

27.

Rapid molecular technique analysis of a KPC-3-producing Klebsiella pneumoniae outbreak in an Italian surgery unit.

Mazzariol A, Lo Cascio G, Ballarini P, Ligozzi M, Soldani F, Fontana R, Cornaglia G.

J Chemother. 2012 Apr;24(2):93-6. doi: 10.1179/1120009X12Z.00000000020.

PMID:
22546764
28.

Carbapenemase-producing Enterobacteriaceae: a call for action!

Nordmann P, Cornaglia G.

Clin Microbiol Infect. 2012 May;18(5):411-2. doi: 10.1111/j.1469-0691.2012.03795.x. No abstract available.

29.

NDM-1-producing Klebsiella pneumoniae, Croatia.

Mazzariol A, Bošnjak Z, Ballarini P, Budimir A, Bedenić B, Kalenić S, Cornaglia G.

Emerg Infect Dis. 2012 Mar;18(3):532-4. doi: 10.3201/eid1803.1103890. No abstract available.

30.

Description and plasmid characterization of qnrD determinants in Proteus mirabilis and Morganella morganii.

Mazzariol A, Kocsis B, Koncan R, Kocsis E, Lanzafame P, Cornaglia G.

Clin Microbiol Infect. 2012 Mar;18(3):E46-8. doi: 10.1111/j.1469-0691.2011.03728.x. Epub 2011 Dec 22.

31.

Outbreak of linezolid-resistant Staphylococcus haemolyticus in an Italian intensive care unit.

Mazzariol A, Lo Cascio G, Kocsis E, Maccacaro L, Fontana R, Cornaglia G.

Eur J Clin Microbiol Infect Dis. 2012 Apr;31(4):523-7. doi: 10.1007/s10096-011-1343-6. Epub 2011 Jul 27.

PMID:
21792559
32.

Pilot implementation of the e-Bug Project in Italy.

Koncan R, Lo Cascio G, Cornaglia G.

J Antimicrob Chemother. 2011 Jun;66 Suppl 5:v75-6. doi: 10.1093/jac/dkr130.

PMID:
21680594
33.

Healthcare workers and influenza vaccination: an ERS-ESCMID Web-based survey.

Blasi F, Palange P, Rohde G, Severin T, Cornaglia G, Finch R.

Clin Microbiol Infect. 2011 Aug;17(8):1223-5. doi: 10.1111/j.1469-0691.2011.03501.x. Epub 2011 May 20.

34.

Professional challenges and opportunities in clinical microbiology and infectious diseases in Europe.

Read RC, Cornaglia G, Kahlmeter G; European Society of Clinical Microbiology and Infectious Diseases Professional Affairs Workshop group.

Lancet Infect Dis. 2011 May;11(5):408-15. doi: 10.1016/S1473-3099(10)70294-2. Review.

PMID:
21530895
35.

Metallo-β-lactamases: a last frontier for β-lactams?

Cornaglia G, Giamarellou H, Rossolini GM.

Lancet Infect Dis. 2011 May;11(5):381-93. doi: 10.1016/S1473-3099(11)70056-1. Review.

PMID:
21530894
36.

A novel VIM-type metallo-beta-lactamase (VIM-14) in a Pseudomonas aeruginosa clinical isolate from a neonatal intensive care unit.

Mazzariol A, Mammina C, Koncan R, Di Gaetano V, Di Carlo P, Cipolla D, Corsello G, Cornaglia G.

Clin Microbiol Infect. 2011 May;17(5):722-4. doi: 10.1111/j.1469-0691.2010.03424.x. Epub 2010 Dec 14.

37.

Sometimes they come back--the return of influenza.

Cornaglia G, Raoult D.

Clin Microbiol Infect. 2011 May;17(5):647-8. doi: 10.1111/j.1469-0691.2010.03455.x. Epub 2011 Mar 3. No abstract available.

38.

New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia?

Rolain JM, Parola P, Cornaglia G.

Clin Microbiol Infect. 2010 Dec;16(12):1699-701. doi: 10.1111/j.1469-0691.2010.03385.x. No abstract available.

39.

Supranational surveillance of antimicrobial resistance: The legacy of the last decade and proposals for the future.

Giske CG, Cornaglia G; ESCMID Study Group on Antimicrobial Resistance Surveillance (ESGARS).

Drug Resist Updat. 2010 Aug-Oct;13(4-5):93-8. doi: 10.1016/j.drup.2010.08.002. Epub 2010 Sep 22. Review.

PMID:
20864384
40.

A European care bundle for management of ventilator-associated pneumonia.

Rello J, Chastre J, Cornaglia G, Masterton R.

J Crit Care. 2011 Feb;26(1):3-10. doi: 10.1016/j.jcrc.2010.04.001.

PMID:
20537504
41.

Identification of a blaVIM-4 gene in the internationally successful Klebsiella pneumoniae ST11 clone and in a Klebsiella oxytoca strain in Hungary.

Kristóf K, Tóth A, Damjanova I, Jánvári L, Konkoly-Thege M, Kocsis B, Koncan R, Cornaglia G, Szego E, Nagy K, Szabó D.

J Antimicrob Chemother. 2010 Jun;65(6):1303-5. doi: 10.1093/jac/dkq133. Epub 2010 Apr 21. No abstract available.

PMID:
20410063
42.

A European survey of antibiotic management of methicillin-resistant Staphylococcus aureus infection: current clinical opinion and practice.

Dryden M, Andrasevic AT, Bassetti M, Bouza E, Chastre J, Cornaglia G, Esposito S, French G, Giamarellou H, Gyssens IC, Nathwani D, Unal S, Voss A.

Clin Microbiol Infect. 2010 Mar;16 Suppl 1:3-30. doi: 10.1111/j.1469-0691.2010.03135.x. Review.

43.

A European care bundle for prevention of ventilator-associated pneumonia.

Rello J, Lode H, Cornaglia G, Masterton R; VAP Care Bundle Contributors.

Intensive Care Med. 2010 May;36(5):773-80. doi: 10.1007/s00134-010-1841-5. Epub 2010 Mar 18.

PMID:
20237759
44.

Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues.

Miriagou V, Cornaglia G, Edelstein M, Galani I, Giske CG, Gniadkowski M, Malamou-Lada E, Martinez-Martinez L, Navarro F, Nordmann P, Peixe L, Pournaras S, Rossolini GM, Tsakris A, Vatopoulos A, Cantón R.

Clin Microbiol Infect. 2010 Feb;16(2):112-22. doi: 10.1111/j.1469-0691.2009.03116.x. Review.

45.

Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control.

Carmeli Y, Akova M, Cornaglia G, Daikos GL, Garau J, Harbarth S, Rossolini GM, Souli M, Giamarellou H.

Clin Microbiol Infect. 2010 Feb;16(2):102-11. doi: 10.1111/j.1469-0691.2009.03115.x. Review.

46.

The emerging threat of acquired carbapenemases in Gram-negative bacteria.

Cornaglia G, Rossolini GM.

Clin Microbiol Infect. 2010 Feb;16(2):99-101. doi: 10.1111/j.1469-0691.2009.03114.x. No abstract available.

47.

Public health microbiology, a challenge for Europe.

Baquero F, Cantón R, Cornaglia G.

Clin Microbiol Infect. 2010 Feb;16(2):123-5. doi: 10.1111/j.1469-0691.2009.03126.x. Epub 2009 Nov 20. No abstract available.

48.

Forthcoming therapeutic perspectives for infections due to multidrug-resistant Gram-positive pathogens.

Cornaglia G, Rossolini GM.

Clin Microbiol Infect. 2009 Mar;15(3):218-23. doi: 10.1111/j.1469-0691.2009.02740.x. Review.

49.

Fighting infections due to multidrug-resistant Gram-positive pathogens.

Cornaglia G.

Clin Microbiol Infect. 2009 Mar;15(3):209-11. doi: 10.1111/j.1469-0691.2009.02737.x.

50.

Comment on: Redefining extended-spectrum beta-lactamases: balancing science and clinical need.

Bush K, Jacoby GA, Amicosante G, Bonomo RA, Bradford P, Cornaglia G, Garau J, Giamarellou H, Jarlier V, Martinez-Martinez L, Miriagou V, Palzkill T, Pascual A, Rodriguez-Baño J, Rossolini GM, Sougakoff W, Vatopoulos A.

J Antimicrob Chemother. 2009 Jul;64(1):212-3; author reply 213-5. doi: 10.1093/jac/dkp104. Epub 2009 Mar 24. No abstract available.

PMID:
19318363

Supplemental Content

Loading ...
Support Center